Glucagon-Like Peptide 1 (GLP-1) Agonists Market Size, Share, growth, Trends, Analysis, Forecast

March 29, 2023 | Author: samidha28jain | Category:
Share Embed Donate


Short Description

Download Glucagon-Like Peptide 1 (GLP-1) Agonists Market Size, Share, growth, Trends, Analysis, Forecast...

Description

Glucagon-like peptide-1 receptor agonists (GLP-1 agonists) are well-known as effective therapy for type 2 diabetes. GLP-1 RAs stimulate GLP-1 receptors, which increase insulin production and decrease glucagon release. Although all GLP-1 RAs work in the same way, they differ in terms of formulations, administration, injectable methods, and dosages. With six GLP-1 RAs currently available in Europe (immediate-release exenatide, lixisenatide, liraglutide; prolonged-release exenatide, dulaglutide, and semaglutide), each with their own characteristics and administration requirements, physicians caring for patients in their routine practise face the challenge of being aware of all of this information so they can select the agent that is most suitable for their patient and use it in an efficient and optimal manner
View more...

Comments

Copyright � 2017 NANOPDF Inc.
SUPPORT NANOPDF